Jurors urged to impose heavy punitive damages in J&J talc trial
By Brendan Pierson (Reuters) - Lawyers for a California man who says he developed a rare…
N2:HEA
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen's…
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of…
J&J faces new trial over talc cancer claims, amid settlement push
By Brendan Pierson (Reuters) -Johnson & Johnson on Wednesday faced the first trial in…
Walgreens reaches $230 million opioid settlement with San Francisco
By Jonathan Stempel (Reuters) -San Francisco said on Wednesday it reached a $230 million…
Altria faces first trial over claims it helped market Juul to teens
By Brendan Pierson (Reuters) - Tobacco giant Altria Group Inc is set to face trial Monday…
Exclusive-US to build $300 million database to fuel Alzheimer’s…
By Julie Steenhuysen CHICAGO (Reuters) - The U.S. National Institute on Aging (NIA) is…